Reckitt Benckiser Group (RBGLY) Stock Rating Lowered by Zacks Investment Research

Reckitt Benckiser Group (OTCMKTS:RBGLY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “

Separately, JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Reckitt Benckiser Group in a report on Monday, December 18th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company’s stock. Reckitt Benckiser Group has an average rating of “Hold” and an average target price of $21.00.

Shares of Reckitt Benckiser Group (RBGLY) traded up $0.30 on Friday, reaching $19.54. The company’s stock had a trading volume of 155,426 shares, compared to its average volume of 684,965. Reckitt Benckiser Group has a 12 month low of $16.84 and a 12 month high of $21.55. The company has a debt-to-equity ratio of 1.94, a quick ratio of 0.67 and a current ratio of 0.86.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Get a free copy of the Zacks research report on Reckitt Benckiser Group (RBGLY)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.

Leave a Reply